Description
iCAD is dedicated to creating a world where cancer cannot hide, developing advanced artificial intelligence solutions for early cancer detection. Their core offering, the ProFound Breast Health Suite, is designed to empower both healthcare providers and patients. This suite comprises three key components: Detection, Density, and Risk assessment.
Read More
The ProFound AI Detection solution revolutionizes mammography screenings by identifying cancers earlier and with greater accuracy and efficiency. It supports both 2D and 3D mammography and is available globally. By integrating this AI into their workflow, radiologists can reduce reading time, minimize recalls, and improve overall patient care.
Complementing detection, the ProFound AI Density assessment provides objective, reliable, and consistent scoring of breast density. Understanding breast density is crucial as it can significantly elevate breast cancer risk. This feature simplifies and standardizes density assessments, providing clinicians with dependable results that can inform personalized treatment plans.
The ProFound AI Risk evaluation introduces the world's first image-based risk model, which is reported to be 2.4 times more accurate than traditional methods. This capability helps identify women at high risk of developing cancer before or at their next screening, enabling proactive measures and earlier detection of interval cancers. It's important to note that ProFound AI Risk is CE Marked and Health Canada Licensed, and available in the US for investigational use.
iCAD's platform is built for seamless integration into existing workflows, offering flexible and secure deployment options for smooth IT adoption. The company emphasizes its commitment to clinical evidence and proven patient outcomes, backed by extensive experience and a large dataset of trained algorithms. They have been instrumental in reading millions of mammograms worldwide, contributing significantly to advancements in breast cancer screening technology.
- CategoryMedical & Clinical AI
- Pricing ModelContact sales
- DeploymentFlexible & Secure
- PlatformsWeb
iCAD's Core Features
AI-powered cancer detection for mammography
Breast density assessment with objective scoring
Image-based breast cancer risk evaluation
Supports 2D and 3D mammography
Reduces radiologist reading time
Aims to improve cancer detection accuracy
Designed for seamless workflow integration
Flexible and secure deployment options
Clinically proven AI solutions
Available globally in various countries
Investigational use in the US for risk assessment
How to use iCAD?
Integrate: Implement ProFound AI solutions into your existing mammography workflow.
Configure: Set up deployment options for flexible and secure IT adoption.
Detect: Utilize AI-powered detection for earlier and more accurate cancer identification.
Assess Density: Employ objective density scoring to inform personalized treatment plans.
Evaluate Risk: Use image-based risk models to identify high-risk patients.
Optimize: Enhance reading efficiency and improve patient outcomes.
iCAD's Use Cases
- Early Cancer Detection
- Mammography Workflow Enhancement
- Breast Density Assessment
- High-Risk Patient Identification
- Interval Cancer Reduction
- Personalized Treatment Planning
